{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T06:01:39Z","timestamp":1785304899223,"version":"3.55.0"},"reference-count":32,"publisher":"Baskent University","issue":"Supp 2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Exp Clin Transplant"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.6002\/ect.mesot2025.l16","type":"journal-issue","created":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T08:49:07Z","timestamp":1785228547000},"source":"Crossref","is-referenced-by-count":0,"title":[],"prefix":"10.6002","volume":"24","member":"4021","reference":[{"key":"ref0","doi-asserted-by":"publisher","unstructured":"1. Martin F, Carmona M, Mahillo B, et al. Organ donation and transplantation worldwide: the Global Observatory on Donation and Transplantation 2024 report. Transplantation. 2026;110(3):e655-e669. doi:10.1097\/TP.0000000000005657","DOI":"10.1097\/TP.0000000000005657"},{"key":"ref1","doi-asserted-by":"publisher","unstructured":"2. Lentine KL, Smith JM, Hart A, et al. OPTN\/SRTR 2020 Annual data report: kidney. Am J Transplant. 2022;22 Suppl 2:21-136. doi:10.1111\/ajt.16982","DOI":"10.1111\/ajt.16982"},{"key":"ref2","doi-asserted-by":"publisher","unstructured":"3. Bisigniano L, Lopez-Rivera A, Tagliafichi V, Fernandez VJ, Soratti CA. Analysis of mortality while on waiting list for kidney transplant in adults in Argentina 2005-2009. Transplant Proc. 2012;44(7):2239-2241. doi:10.1016\/j.transproceed.2012.07.128","DOI":"10.1016\/j.transproceed.2012.07.128"},{"key":"ref3","doi-asserted-by":"publisher","unstructured":"4. Holscher CM, Jackson KR, Segev DL. Transplanting the untransplantable. Am J Kidney Dis. 2020;75(1):114-123. doi:10.1053\/j.ajkd.2019.04.025","DOI":"10.1053\/j.ajkd.2019.04.025"},{"key":"ref4","doi-asserted-by":"publisher","unstructured":"5. Segev DL, Gentry SE, Melancon JK, Montgomery RA. Characterization of waiting times in a simulation of kidney paired donation. Am J Transplant. 2005;5(10):2448-2455. doi:10.1111\/j.1600-6143.2005.01048.x","DOI":"10.1111\/j.1600-6143.2005.01048.x"},{"key":"ref5","doi-asserted-by":"publisher","unstructured":"6. Takahashi K, Saito K. ABO-incompatible kidney transplantation. Transplant Rev (Orlando). 2013;27(1):1-8. doi:10.1016\/j.trre.2012.07.003","DOI":"10.1016\/j.trre.2012.07.003"},{"key":"ref6","doi-asserted-by":"publisher","unstructured":"7. Uchida J, Kosoku A, Naganuma T, Tanaka T, Nakatani T. Latest insights on ABO-incompatible living-donor renal transplantation. Int J Urol. 2020;27(1):30-38. doi:10.1111\/iju.14109","DOI":"10.1111\/iju.14109"},{"key":"ref7","unstructured":"8. Landsteiner K. On agglutination manifestations of normal human blood. Wiener Klinische Wochenschrift. 1901;14:1132-1134."},{"key":"ref8","unstructured":"9. Starzl TE, Marchioro TL, Holmes JH, et al. Renal homografts in patients with major donor-recipient blood group incompatibilities. Surgery. 1964;55:195-200."},{"key":"ref9","doi-asserted-by":"publisher","unstructured":"10. Hadaya K. [ABO incompatible renal transplantation]. Rev Med Suisse. 2012;8(346):1310-1313.","DOI":"10.53738\/REVMED.2012.8.346.1310"},{"key":"ref10","unstructured":"11. Alexandre GP, Squifflet JP, De Bruyere M, et al. Present experiences in a series of 26 ABO-incompatible living donor renal allografts. Transplant Proc. 1987;19(6):4538-4542."},{"key":"ref11","doi-asserted-by":"publisher","unstructured":"12. Opelz G, Morath C, Susal C, Tran TH, Zeier M, Dohler B. Three-year outcomes following 1420 ABO-incompatible living-donor kidney transplants performed after ABO antibody reduction: results from 101 centers. Transplantation. 2015;99(2):400-404. doi:10.1097\/TP.0000000000000312","DOI":"10.1097\/TP.0000000000000312"},{"key":"ref12","doi-asserted-by":"publisher","unstructured":"13. Okumi M, Toki D, Nozaki T, et al. ABO-incompatible living kidney transplants: evolution of outcomes and immunosuppressive management. Am J Transplant. 2016;16(3):886-896. doi:10.1111\/ajt.13502","DOI":"10.1111\/ajt.13502"},{"key":"ref13","doi-asserted-by":"publisher","unstructured":"14. Kosoku A, Uchida J, Nishide S, et al. ABO-incompatible kidney transplantation as a renal replacement therapy-a single low-volume center experience in Japan. PLoS One. 2018;13(12):e0208638. doi:10.1371\/journal.pone.0208638","DOI":"10.1371\/journal.pone.0208638"},{"key":"ref14","doi-asserted-by":"publisher","unstructured":"15. Scurt FG, Ewert L, Mertens PR, Haller H, Schmidt BMW, Chatzikyrkou C. Clinical outcomes after ABO-incompatible renal transplantation: a systematic review and meta-analysis. Lancet. 2019;393(10185):2059-2072. doi:10.1016\/S0140-6736(18)32091-9","DOI":"10.1016\/S0140-6736(18)32091-9"},{"key":"ref15","doi-asserted-by":"publisher","unstructured":"16. Bohmig GA, Farkas AM, Eskandary F, Wekerle T. Strategies to overcome the ABO barrier in kidney transplantation. Nat Rev Nephrol. 2015;11(12):732-747. doi:10.1038\/nrneph.2015.144","DOI":"10.1038\/nrneph.2015.144"},{"key":"ref16","doi-asserted-by":"publisher","unstructured":"17. Takahashi K. A new concept of accommodation in ABO-incompatible kidney transplantation. Clin Transplant. 2005;19 Suppl 14:76-85. doi:10.1111\/j.1399-0012.2005.00392.x","DOI":"10.1111\/j.1399-0012.2005.00392.x"},{"key":"ref17","doi-asserted-by":"publisher","unstructured":"18. Kaplan B, Gangemi A, Thielke J, Oberholzer J, Sankary H, Benedetti E. Successful rescue of refractory, severe antibody mediated rejection with splenectomy. Transplantation. 2007;83(1):99-100. doi:10.1097\/01.tp.0000243739.31440.2b","DOI":"10.1097\/01.tp.0000243739.31440.2b"},{"key":"ref18","doi-asserted-by":"publisher","unstructured":"19. Tyden G, Kumlien G, Fehrman I. Successful ABO-incompatible kidney transplantations without splenectomy using antigen-specific immunoadsorption and rituximab. Transplantation. 2003;76(4):730-731. doi:10.1097\/01.TP.0000078622.43689.D4","DOI":"10.1097\/01.TP.0000078622.43689.D4"},{"key":"ref19","doi-asserted-by":"publisher","unstructured":"20. Ishida H, Miyamoto N, Shirakawa H, et al. Evaluation of immunosuppressive regimens in ABO-incompatible living kidney transplantation--single center analysis. Am J Transplant. 2007;7(4):825-831. doi:10.1111\/j.1600-6143.2006.01676.x","DOI":"10.1111\/j.1600-6143.2006.01676.x"},{"key":"ref20","doi-asserted-by":"publisher","unstructured":"21. Herzog AL, Kalogirou C, Wanner C, Lopau K. Safety and efficacy of induction therapy with thymoglobulin in AB0-incompatible kidney transplantation. Transplant Proc. 2018;50(1):53-59. doi:10.1016\/j.transproceed.2017.12.010","DOI":"10.1016\/j.transproceed.2017.12.010"},{"key":"ref21","doi-asserted-by":"publisher","unstructured":"22. Nayak S, Makroo RN, Prakash B, et al. Comparative evaluation of five different methods of anti-ABO antibody titration: an aid for ABO-incompatible organ transplants. Ther Apher Dial. 2019;23(1):86-91. doi:10.1111\/1744-9987.12745","DOI":"10.1111\/1744-9987.12745"},{"key":"ref22","doi-asserted-by":"publisher","unstructured":"23. Perry H, Bovin N, Henry S. A standardized kodecyte method to quantify ABO antibodies in undiluted plasma of patients before ABO-incompatible kidney transplantation. Transfusion. 2019;59(6):2131-2140. doi:10.1111\/trf.15247","DOI":"10.1111\/trf.15247"},{"key":"ref23","doi-asserted-by":"publisher","unstructured":"24. Kim HJ, Jung HY, Choi JY, et al. Application of flow cytometry to measure anti-A\/B antibody in ABO-incompatible kidney transplantation. Transplant Proc. 2015;47(3):591-595. doi:10.1016\/j.transproceed.2014.11.046","DOI":"10.1016\/j.transproceed.2014.11.046"},{"key":"ref24","doi-asserted-by":"publisher","unstructured":"25. Axelrod D, Lentine KL, Schnitzler MA, et al. The incremental cost of incompatible living donor kidney transplantation: a national cohort analysis. Am J Transplant. 2017;17(12):3123-3130. doi:10.1111\/ajt.14392","DOI":"10.1111\/ajt.14392"},{"key":"ref25","unstructured":"26. Glycorex Transplantation. Glycosorb ABO product information."},{"key":"ref26","doi-asserted-by":"publisher","unstructured":"27. Schiesser M, Steinemann DC, Hadaya K, et al. The reuse of immunoadsorption columns in ABO-incompatible kidney transplantation is efficient: the Swiss experience. Transplantation. 2015;99(5):1030-1035. doi:10.1097\/TP.0000000000000457","DOI":"10.1097\/TP.0000000000000457"},{"key":"ref27","doi-asserted-by":"publisher","unstructured":"28. Barnett AN, Manook M, Nagendran M, et al. Tailored desensitization strategies in ABO blood group antibody incompatible renal transplantation. Transpl Int. 2014;27(2):187-196. doi:10.1111\/tri.12234","DOI":"10.1111\/tri.12234"},{"key":"ref28","doi-asserted-by":"publisher","unstructured":"29. Redfield RR, Parsons RF, Rodriguez E, et al. Underutilization of A2 ABO incompatible kidney transplantation. Clin Transplant. 2012;26(3):489-494. doi:10.1111\/j.1399-0012.2011.01543.x","DOI":"10.1111\/j.1399-0012.2011.01543.x"},{"key":"ref29","doi-asserted-by":"publisher","unstructured":"30. Barnett AN, Hudson A, Hadjianastassiou VG, et al. Distribution of ABO blood group antibody titers in pediatric patients awaiting renal transplantation: implications for organ allocation policy. Transplantation. 2012;94(4):362-368. doi:10.1097\/TP.0b013e31825b7608","DOI":"10.1097\/TP.0b013e31825b7608"},{"key":"ref30","doi-asserted-by":"publisher","unstructured":"31. de Weerd AE, Betjes MGH. ABO-incompatible kidney transplant outcomes: a meta-analysis. Clin J Am Soc Nephrol. 2018;13(8):1234-1243. doi:10.2215\/CJN.00540118","DOI":"10.2215\/CJN.00540118"},{"key":"ref31","doi-asserted-by":"publisher","unstructured":"32. Renner FC, Wienzek-Lischka S, Feustel A, et al. Impact of pretransplant intravenous immunoglobulin administration on anti-AB0 antibody levels in AB0-incompatible living donor kidney transplantation. Transplant Proc. 2010;42(10):4003-4005. doi:10.1016\/j.transproceed.2010.09.058","DOI":"10.1016\/j.transproceed.2010.09.058"}],"container-title":["Experimental and Clinical Transplantation"],"original-title":[],"deposited":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T05:25:42Z","timestamp":1785302742000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ectrx.org\/detail\/supplement\/2026\/24\/6\/2\/10\/0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":32,"journal-issue":{"issue":"Supp 2","published-print":{"date-parts":[[2026,7]]}},"URL":"https:\/\/doi.org\/10.6002\/ect.mesot2025.l16","relation":{},"ISSN":["1304-0855","2146-8427"],"issn-type":[{"value":"1304-0855","type":"print"},{"value":"2146-8427","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7]]}}}